m+Medelevator.RU
← Поиск публикаций
BMC ophthalmology · 2026

Changes in visual acuity and corneal aberrations after presbyopia correction using micro-monovision multifocal bi-aspheric ablation: six-month results.

Клиническое исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Wang Xiaofan, Li Li, Lin Yinuo, Ji Peng, Tang Yifan, Xian Suqi, Bi Hongsheng

Аннотация

AIM: To assess visual outcomes and corneal aberration changes following micro-monovision multifocal bi-aspheric ablation (PresbyMax monocular) for presbyopia correction. METHOD: 25 patients (50 eyes) underwent PresbyMAX monocular treatment. Pre and postoperative evaluations (1 week, 1, 3, and 6 months) included uncorrected distance (UDVA), intermediate (UIVA), near (UNVA), and corrected distance visual acuity (CDVA). Corneal aberration and Strehl ratio (SR) were analyzed within 3-mm and 6-mm zones. The National Eye Institute 25-Item Visual Function Questionnaire (NEI-VFQ-25) was used to assess visual function preoperatively and at 6 months postoperatively. RESULT: At 6 months, binocular UDVA and UIVA were 0 (− 0.1, 0) logMAR and − 0.1 (− 0.1, 0) logRAD, respectively. Spectacle independence reached 96%, with 96%, 100%, and 96% achieving UDVA ≥ 0.1 logMAR, UIVA ≥ 0.1 logRAD, and UNVA ≥J1. No eyes lost corrected distance visual acuity. In non-dominant eyes, 3-mm corneal zones exhibited negative shifts in fourth-order spherical aberration ([Formula: see text]) and sixth-order spherical aberration ([Formula: see text]) (both p < 0.001). In 6-mm corneal zones, [Formula: see text] exhibited no significant change; however, compared to the dominant eye, it was significantly more negative (p < 0.001). [Formula: see text] increased positively with a statistically significant difference (p < 0.001). NEI-VFQ-25 scores improved from 74.63 (71.70, 81.81) to 91.15 (85.23, 93.08) (p < 0.001). CONCLUSION: The PresbyMAX protocol enhances near vision by strategically manipulating aberrations to increase depth of focus in the non-dominant eye, while the dominant eye maintains distance and intermediate vision. This synergistic binocular approach achieves satisfactory full-range vision, resulting in a 96% spectacle independence rate and high patient satisfaction. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR2300074821, registration date 2023-08-17.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты